Recent studies revealed that hepatic GH-STAT5 signaling not only prevents steatosis, but also has protective functions in the context of genetically or chemically induced liver fibrosis and cancer development15, 37 (Friedbichler et al., unpublished). This evidence concerns the gene STAT5B and steatosis.